-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Poseida Therapeutics, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2019 to 2023.
- Poseida Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was $20.2M.
- Poseida Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$60.8M, a 53.8% increase year-over-year.
- Poseida Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$123M, a 92.9% decline from 2022.
- Poseida Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$64M, a 48.8% increase from 2021.
- Poseida Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$125M, a 3.7% increase from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)